Burning Rock Biotech and Bayer Enter Strategic Collaboration on Companion Diagnostics for Oncology Products

Mr. Hans Rain, Founder and CEO of Burning Rock Biotech Ltd, said"We are very pleased to reach a companion diagnostic collaboration with Bayer, a global leading biopharmaceutical company. Burning Rock Biotech is fully committed to supporting pharmaceutical enterprises in the development of companion diagnostics from a global perspective. We believe that by integrating resources and experience in the field of oncology diagnosis and treatment, this collaboration will set a standardized, high-standard example for the joint development of precision diagnostics and new anti-tumor drugs. It will make a greater contribution to the advancement of precision oncology and bring more effective treatment options to patients while setting a new benchmark in the medical field."